Effect of albumin on the estimation, in vitro, of phenytoin V(max) and K(m) values: Implications for clinical correlation

Journal of Pharmacology and Experimental Therapeutics

Volumn 282, Issue 1, 1997, Pages 391-396

  Ludden, Linda K ^a,b   Ludden, Thomas M ^a,b   Collins, Jerry M ^a   Pentikis, Helen S ^a,c   Strong, John M ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c Drug Metab Pharmacokin Department   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 (4 HYDROXYPHENYL) 5 PHENYLHYDANTOIN; BOVINE SERUM ALBUMIN; PHENYTOIN; PHENYTOIN DERIVATIVE;

ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER MICROSOME METABOLISM; MICHAELIS CONSTANT; PRIORITY JOURNAL;

ANTICONVULSANTS; HUMANS; MICROSOMES, LIVER; PHENYTOIN; SERUM ALBUMIN, BOVINE;

EID: 0030825141     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. AKAIKE H.: A new look at the statistical model identification. IEEE Trans. Automat. Contr. 19: 716-723, 1974.
2. ASHFORTH, E. I. L., CARLILE, D. J., CHENERY, R. AND HOUSTON, J. B.: Prediction of in vivo disposition from in vitro systems: Clearance of phenytoin and tolbutamide using rat hepatic microsomal and hepatocyte data. J. Pharmacol. Exp. Ther. 274: 761-766, 1995.
3. BAJPAI, M., ROSKOS, L. K., SHEN, D. D., TRAGER, W. F. AND LEVY, R. H.: Role of s-mephenytoin hydroxylase in the metabolism of phenytoin (Abstract). Pharm. Res. 11(Suppl.): S-438, 1994.
4. BENET, L. Z., ØIE, S., SCHWARTZ, J. B.: Design and optimization of dosage regimens; pharmacokinetic data. In Goodman & Gilman's The Pharmacological Basis of Therapeutics, Ninth Edition, ed. by J. G. Hardman, L. E. Limbird, P. B. Molinoff, R. W. Ruddon and A. G. Gilman, pp. 1707-1792, McGraw-Hill Companies, Inc., New York, 1996.
5. BROWNE, T. R., EVANS, J. E., SZABO, G. K., EVANS, B. A., GREENBLATT, D. J. AND SCHUMACHER, G. E.: Studies with stable isotopes I: Changes in phenytoin pharmacokinetics and biotransformation during monotherapy. J. Clin. Pharmacol. 25: 43-50, 1985.
6. DOECKE, C. J., VERONESE, M. E., POND, S. M., MINERS, J. O., BIRKETT, D. J., SANSOM, L. N. AND MCMANUS, M. E.: Relationship between phenytoin and tolbutamide hydroxylations in human liver microsomes. Br. J. Clin. Pharmac. 31: 125-130, 1991.
7. DOGTEROM, P.: Development of a simple incubation system for metabolism studies with precision-cut liver slices. Drug Metab. Dispos. 21: 699-704, 1993.
8. GRASELA, T. H., SHEINER, L. B., RAMBECK, B., BOENIGK, H. E., DUNLOP, A., MULLEN, P. W., WADSWORTH, J., RICHENS, A., ISHIZAKE, T., CHIBA, K., MIURA. H., MINAGAWA, K., BLAIN, P. G., MUCKLOW, J. C., BACON, C. T. AND RAWLINS, M.: Steady-state pharmacokinetics of phenytoin from routinely collected patient data. Clin. Pharmacokin. 8: 355-364, 1983.
9. KAPETANOVIC, I. M. AND KUPFERBERG, J. J.: Nafimidone, an imidazole anticonvulsant, and its metabolite as potent inhibitors of microsomal metabolism of phenytoin and carbamazepine. Drug Metab. Dispos. 12: 560-564, 1984.
10. LAKE, B. G.: Preparation and characterization of microsomal fractions for studies on xenobiotic metabolism. In Biochemical Toxicology: A Practical Approach, ed. by K. Snell and B. Mullock, pp. 183-187. IRL Press, Washington, DC, 1987.
11. LEVY, R. H.: Cytochrome P450 isozymes and antiepileptic drug interactions. Epilepsia (Suppl) 5: 8-13, 1995.
12. LUDDEN, T. M., ALLEN, J. P., VALUTSKY, W. A., VICUNA, A. V., NAPPI, J. M., HOFFMAN, S. F., WALLACE, J. E., LALKA, D. AND MCNAY, J. L.: Individualization of phenytoin dosage regimens. Clin. Pharmacol. Ther. 21: 287-293, 1977.
13. PANG, K. S. AND CHIBA, M.: Metabolism: scaling-up from in vitro to organ and whole body. In Pharmacokinetics of Drugs: Handbook of Experimental Pharmacology, Vol 110, ed. by P. G. Welling and L. P. Balant, pp. 101-187, Springer-Verlag, Berlin, Germany, 1994.
14. PECK, C. C., TEMPLE, R. AND COLLINS, J. M.: Understanding consequences of concurrent therapies. JAMA 269: 1550-1552, 1993.
15. PETERS, T.: All About Albumin, pp. 188-250, Academic Press, Inc., San Diego, CA, 1996.
16. SCHMUCKER, D. L., WOODHOUSE, K. W., WANG, R. K., WYNNE, H., JAMES, O. F., MCMANUS, M. AND KREMERS, P.: Effects of age and gender on in vitro properties of human liver microsomal monooxygenases. Clin. Pharmacol. Ther. 48: 365-374, 1990.
17. SCHWARTZ, P. A., RHODES, C. T. AND COOPER JR., J. W.: Solubility and ionization characteristics of phenytoin. J. Pharm. Sci. 66: 994-997, 1977.
18. SPIELBERG, S., MCCREA, J., CRIBB, A., RUSHMORE, T., WALDMAN, S., BJORNSSON, T., LO, M.-W. AND GOLDBERG, M.: A mutation in CYP2C9 is responsible for decreased metabolism of losartan. (Abstract). Clin. Pharmacol. Ther. 59: 215, 1996.
19. TABURET, A. M., VINCENT, I., PERELLO, L., CORET, B., BAUNE, B., FURLAN, V.: Impairment of drug biotransformation in renal disease: An in vitro model. (Abstract). Clin. Pharmacol. Ther. 59: 136, 1996.
20. TOZER, T. N. AND WINTER, M. E.: Phenytoin. In Applied Pharmacokinetics: Principles of Therapeutic Drug Monitoring, 3rd ed., ed. by W. E. Evans, J. J. Schentag and W. J. Jusko, pp. 25-1 to 25-44, Applied Therapeutics, Inc., Vancouver, WA, 1992.
21. VICKERS, A. E. M., FISCHER, V., CONNORS, S., FISHER, R. L., BALDECK, J.-P., MAURER, G., BRENDEL, K.: Cyclosporin A metabolism in human liver, kidney, and intestine slices: Comparison to rat and dog slices and human cell lines. Drug Metab. Dispos. 20: 802-809, 1992.
22. VICKERS, A. E. M., CONNORS, S., ZOLLINGER, M., BIGGI, W. A., LARRAURI, A., VOGELAAR, J. P. W. AND BRENDEL, K.: The biotransformation of the ergot derivative CQA 206-291 in human, dog, and rat liver slice cultures and prediction of in vivo plasma clearance. Drug Metab. Dispos. 21: 454-459, 1993.
23. WORBOYS, P. D., BRADBURY, A. AND HOUSTON, J. B.: Kinetics of drug metabolism in rat liver slices: Rates of oxidation of ethoxycoumarin and tolbutamide, examples of high- and low-clearance compounds. Drug Metab. Dispos. 23: 393-397, 1995.
24. WORBOYS, P. D., BRADBURY, A. AND HOUSTON, J. B.: Kinetics of drug metabolism in rat liver slices. II. Comparison of clearance by liver slices and freshly isolated hepatocytes. Drug Metab. Dispos. 24: 676-681, 1996.